Treatment of the 2 to 3 cm Renal Mass

摘要

No AccessJournal of UrologyOpposing Views1 Aug 2010Treatment of the 2 to 3 cm Renal Mass Monish Aron, Inderbir S. Gill, Stephen A. Boorjian, and Robert G. Uzzo Monish AronMonish Aron Center for Robotic Surgery & Advanced Laparoscopy, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California More articles by this author , Inderbir S. GillInderbir S. Gill Center for Robotic Surgery & Advanced Laparoscopy, USC Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California More articles by this author , Stephen A. BoorjianStephen A. Boorjian Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author , and Robert G. UzzoRobert G. Uzzo Department of Urologic Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2010.05.050AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail References 1 : Clinical practice: Small renal mass. N Engl J Med2010; 362: 624. Google Scholar 2 : The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol2006; 175: 425. Link, Google Scholar 3 : Effect of renal cancer tumor size on the prevalence of metastasis at diagnosis and mortality. J Urol2009; 181: 1020. Link, Google Scholar 4 : Predicting growth of solid renal masses under active surveillance. Urol Oncol Semin2008; 26: 555. Google Scholar 5 : Solid renal tumors: an analysis of pathological features related to tumor size. J Urol2003; 170: 2217. Link, Google Scholar 6 : Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol2007; 177: 1692. Link, Google Scholar 7 : Enhancing renal masses with zero net growth during active surveillance. J Urol2007; 177: 849. Link, Google Scholar 8 : Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active aurveillance. Cancer2009; 115: 2844. Google Scholar 9 : Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses. AJR Am J Roentgenol2003; 180: 1281. Google Scholar 10 : 800 Laparoscopic partial nephrectomies: a single surgeon series. J Urol2010; 183: 34. Link, Google Scholar 11 : Laparoscopic renal cryoablation: 8-year, single surgeon outcomes. J Urol2010; 183: 889. Link, Google Scholar 12 : Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst2006; 98: 1331. Google Scholar 13 : Excise, ablate, or observe: the small renal mass dilemma-a meta-analysis and review. J Urol2008; 179: 1227. Link, Google Scholar 14 : A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy. J Urol2007; 178: 429. Link, Google Scholar 15 : Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol2009; 181: 29. Link, Google Scholar 16 : Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am2008; 35: 627. Google Scholar 17 : Delayed intervention of sporadic renal masses under active surveillance. Cancer2008; 112: 1051. Google Scholar 18 : Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol2009; 28: 311. Google Scholar © 2010 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byHeilbrun M, Yu J, Smith K, Dechet C, Zagoria R and Roberts M (2018) The Cost-Effectiveness of Immediate Treatment, Percutaneous Biopsy and Active Surveillance for the Diagnosis of the Small Solid Renal Mass: Evidence From a Markov ModelJournal of Urology, VOL. 187, NO. 1, (39-43), O